What Does Eyp Mean? the Story Behind Eyepoint's Duravyu Implant and Phase 3 Trial Results

Is what Does Eyp Mean? the Story Behind Eyepoint's Duravyu Implant and Phase 3 Trial Results worth your attention? Read key highlights in our dedicated article.

Much of our clinical understanding of EYP stems from the preceding DAVIO 2 Phase 2 trial and its detailed post hoc findings presented at the American Society of Retina Specialists (ASRS) 2026 meeting. Investigators analyzed patients who precisely mirrored the stricter eligibility standards used in Phase 3 trials.

The post hoc data demonstrated remarkable consistency: when clinicians selected patients who had already demonstrated baseline responsiveness to anti-VEGF therapy, EYP-1901 held their vision and retinal anatomy completely stable over nine months. More than 60% of participants went six months without needing a single rescue injection, and nearly half remained injection-free across the entire study period.

Retina specialists have emphasized the real-world value of this stability. In clinical discussions reported by HCPLive, Dr. Avni Finn noted that extending wet AMD durability fundamentally shifts patient well-being. Elderly individuals who struggle with monthly transit, cognitive fatigue, or post-injection ocular soreness gain breathing room. In practice, missing an appointment by three weeks with a standard biologic can trigger catastrophic hemorrhaging; with a six-month continuous depot like DURAVYU resting in the eye, the patient retains an active safety buffer.